Pharmaceutical Company Says Its New Anti-Depressant Is 'Worthless And Dumb'

Top Headlines

Recent News

Siblings Each Hoping Other One Will Take Care Of Aging Parents Someday

CLEVELAND—Explaining that they simply didn’t want to have to deal with the immense time commitment and emotional exhaustion, sisters Katie and Ellen Cattell each privately admitted to reporters this week that they were hoping the other sibling would someday be the one to take care of their aging parents.

Where Your Political Donation Goes

With over $1 billion spent in the 2016 presidential race alone, campaign donations continue to cause much controversy and even confusion for their role in shaping politics. Here is a step-by-step guide to how the average American’s political donation travels through a campaign

Roommate Skulking Around Edge Of Party Like Victorian Ghost Child

SEATTLE—Appearing initially in the far corner of the living room and then several minutes later on the threshold between the kitchen and the hallway, local roommate Kelsey Stahl was, by multiple accounts, seen skulking around the edge of a house party Friday like a Victorian ghost child.

Fact-Checking The Third Presidential Debate

Presidential nominees Hillary Clinton and Donald Trump sparred over subjects including foreign policy, the economy, and their fitness to hold the nation’s highest office in the final debate Wednesday. The Onion examines the validity of their assertions

Man Praying Interviewer Doesn’t Ask Any Questions

MINNEAPOLIS—His mouth going dry and his palms growing sweaty as he arrived at the offices of Regent Advertising Partners to interview for an open account manager position, local man Devin McKee reportedly prayed Thursday that the hiring manager wouldn’t ask him any questions during their meeting.

Origins Of Popular Slang Terms

As the internet helps push new words and expressions into common usage, many may wonder where our most ubiquitous idioms come from. Here are the origins of some popular slang terms and phrases
End Of Section
  • More News
Up Next

Pharmaceutical Company Says Its New Anti-Depressant Is 'Worthless And Dumb'

EAST BRUNSWICK, NJ—At a press conference Monday, Peter Cafazzo, CEO of Brunley-Hunt Pharmaceuticals (BHP), introduced his company's latest anti-depressant, Cyntrex, a product he described as "a totally stupid waste of time that probably nobody will ever want ever."

Peter Cafazzo, CEO of Brunley-Hunt Pharmaceuticals, unveils Cyntrex, a "worthless new drug" that he says will make the company "the total laughingstock of the industry."

Though from the outset, BHP had hoped the new medication would revolutionize the treatment of depression, Cafazzo is less than enthusiastic about its chances against such industry leaders as Prozac and Zoloft.

"Cyntrex? Yeah, right. More like, Stupidtrex," a visibly downcast Cafazzo told reporters. "More like, Another-Awful-Product-That-Will-Probably-Make-Us-All-Bankruptrex. More like, I suck."

The new drug, which stimulates the production of neurotransmitters in sync with the body's natural diurnal catecholamine rhythms—causing a more even mood level than the frequent "crest and trough" patterns associated with traditional psychoactive medicinal treatments—is something that "everybody will laugh at," Cafazzo said.

Among the reasons Cafazzo cited for Cyntrex's "totally doomed future" is BHP's inability to do anything half as well as its chief competitors.

"Prozac is so great," Cafazzo said. "We'll never make anybody as happy as Prozac does. I just know it."

Added Cafazzo: "My life is shit."

The release of Cyntrex is the latest bold move by BHP, which has increased its share of the mental-health drug market from 7 to 11 percent during the five years Cafazzo has been the company's CEO, causing many to view BHP as the rising giant in $150 billion pharmaceutical industry.

Cafazzo, however, questions the validity of such an appraisal. "Eleven percent? Oh, I'm sure. Like a company's really going to do that well with such a total fucking loser asshole for a boss."

"Maybe I'll get a raise," he said. "Then I can use the money to buy a gun to blow my head off."

According to reports, top BHP researchers began having doubts about the drug during the early development stages, when they realized they couldn't do anything right ever ever ever, and that none of the pharmaceutical-industry leaders cared whether they lived or died. But work on the project continued, despite BHP's growing conviction that Cyntrex would be the worst product in pharmaceutical history.

"We should have just stopped trying back then during the development stage," BHP lab assistant Peter Ayers said. "But, no, we had to go and make ourselves look like idiots in front of the whole world. Us and our lousy little pills both. Why?"

Ayers then began beating his fists into the sides of his head while staring at the floor, repeating, "Why? Why, why, why, why, why?" before being restrained by loved ones.

Fellow BHP researcher Harlan Downing said that, in addition to treating depression, Cyntrex may have numerous other uses. "There is a strong possibility," Downing said, "that the particular disinhibitors activated by Cyntrex may be of great benefit in the treatment of Alzheimer's Disease." He then admitted that the drug will not be ready for such use for some time, repeatedly hitting his forehead into a wall and gently mumbling under his breath.

BHP's chief rival in the mood-altering drug field is Stafford Labs, manufacturer of Prozac. Stafford CEO Margaret Curry expressed faith that Prozac would maintain its position despite the new competition.

"We will emerge triumphant, for I am Margaret Curry, president of Stafford Labs!" she said. "My power is as of 50 CEOs! My marketing savvy is as of a legion of PR firms! My tricyclic monoinhibitor is a boon unto the people and a beacon unto the nations! My new promotional campaign to enhance brand awareness and increase market saturation of Prozac shall be cloaked in radiant beams of persuasive glory!"


Sign up For The Onion's Newsletter

Give your spam filter something to do.

X Close